Meanwhile, we hypothesized that FGF1 regulates CRC development via mTOR-S6K1 dependent pathway, and our findings demonstrated a novel role of FGF1 in CRC and identified its potential diagnostic and therapeutic relevance. The gene discussed is MTOR; the disease is colorectal carcinoma.